COVID-PACT - Antithrombotic therapy in critically Ill COVID-19 patients

Reported from ESC Congress 2022

Watch Luis Ortega Paz's interview with David Berg as part of the ESC 2022 Congress coverage, and find out more about the COVID-PACT trial, which aims to study antithrombotic strategies in critically ill COVID-19 patients. Learn more about the study design (population, primary endpoint, safety criteria...) and its first outcomes, before analyzing how to implement these results in practice.